On the other hand, a flow cytometric analysis of glioma tissues from 31 patients showed the presence of immune-suppressive IL-17+FoxP3+ T cells (8% in gliomas versus 0.5–1% in control tissues) [48]. The gene discussed is IL17A; the disease is central nervous system cancer.